chatsaudicam.com

  • Health News

Home » Novartis

Health News 

Novartis Investigational STAMP Inhibitor Asciminib (ABL001) Shows Superior MMR Rate to Bosulif®* in Chronic Myeloid Leukemia Trial

12/10/2020 (ABL001), Asciminib, Bosulif®*, chronic, In, inhibitor, Investigational, Leukemia, MMR, Myeloid, Novartis, rate, shows, STAMP, Superior, to, trial

EAST HANOVER, N.J., Dec. 8, 2020 /PRNewswire/ — Detailed results from the Phase III ASCEMBL study demonstrate that, at 24 weeks, asciminib (ABL001)

Read more
Health News 

New Novartis Analyses for Investigational Inclisiran Demonstrate Consistently Effective and Sustained LDL-C Reduction at Month 17, Regardless of Age and Gender

11/16/2020 17, age, analyses, and, at, Consistently, Demonstrate, effective, for, Gender, Inclisiran, Investigational, LDL-C, month, new, Novartis, of, Reduction, Regardless, Sustained

EAST HANOVER, N.J., Nov. 13, 2020 /PRNewswire/ — Novartis today announced results from two pooled post-hoc analyses of Phase III ORION-9, -10 and

Read more
Recent Posts
  • Best hair loss treatment: Three treatments for hair loss backed by solid evidence
  • Strongman Brian Shaw Just Shared His 5,513 Calorie ‘Fat Loss Diet’
  • Tanni Grey-Thompson health: Paralympian born with spina bifida – what is the condition?
  • Study finds COVID isolation worsens student diets, inactivity, and alcohol intake
  • The Truth About Green Tea and Weight Loss
Copyright © 2021 chatsaudicam.com. All rights reserved.
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok